Skip to main content

Table 3 End points

From: Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study

Outcome

COVID-19 N = 146

H1N1 N = 162

P Value

Length of stay, (days)

 In the ICU

40 (23–78)

25 (17–41)

0.0001

 In the hospital

50 (28–86)

38 (27–53)

0.0001

ECMO duration, (days)

22 (11–38)

13 (9–22)

0.0001

Duration of invasive mechanical ventilation, (days)

33 (20–62)

25 (17–43)

0.002

ECMO associated complications

Hemorrhagic, n (%)

68 (47)

51 (32)

0.009

 Cannula site

32 (22)

22 (14)

0.06

 Airways

40 (28)

21 (13)

0.002

 Gastrointestinal

9 (6)

12 (8)

0.647

 Central nervous system

8 (6)

6 (4)

0.467

Mechanical, n (%)

38 (27)

53 (34)

0.189

 Cannula thrombosis

6 (4)

4 (3)

0.420

 Membrane Clotting

40 (28)

48 (31)

0.649

 Pump malfunction

0 (0)

4 (3)

0.056